Stay updated on Datopotamab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Datopotamab in Lung Cancer Clinical Trial page.

Latest updates to the Datopotamab in Lung Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check20 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe webpage has updated several important dates, including the addition of new dates in 2025 and the removal of previous dates in 2024. Additionally, some identifiers have been modified, which may affect the referencing of specific items.SummaryDifference0.9%
- Check49 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check63 days agoChange DetectedThe webpage has been updated to reflect a new study involving DS-102a for metastatic lung cancer, replacing previous references to DS-1062a. Key details about the study's design, including the number of participants and collaborators, have been revised.SummaryDifference50%
- Check70 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to Datopotamab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Datopotamab in Lung Cancer Clinical Trial page.